We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Phase II

News List

RedHill Biopharma enrols last patient in Phase II irritable bowel syndrome trial europeanpharmaceuticalreview
May 07, 2019
RedHill Biopharma has enrolled the last patient in the Phase II study with Bekinda for the treatment of diarrhoea-predominant irritable bowel syndrome…
Bridge Bio, Daewoong Pharma to Develop New UC Treatment contractpharma
December 21, 2018
Bridge Biotherapeutics Inc., a biotech company headquartered in Seongnam, South Korea, has signed a license agreement with Daewoong Pharmaceutical Co., Ltd.
Dalton, ExCellThera in Development and Mfg. Pact contractpharma
November 27, 2018
Stem cell transplantation is increasingly be used in the treatment of blood and bone marrow cancers and shows potential for autoimmune disorders and other non-malignant diseases.
Phase II Clinical Trials of DCVAC Show Significant Benefit for Patients with Ovarian and Lung Cancer b3cnewswire
June 20, 2018
SOTIO, a biotechnology company owned by the PPF Group, presented results from its Phase II clinical trials evaluating DCVAC, an active cellular immunotherapy product,
Oncolytics, Merck, Northwestern Conduct Phase II Combo Trial contractpharma
May 22, 2018
Oncolytics Biotech Inc., currently developing REOLYSIN (pelareorep), an intravenously delivered immuno-oncolytic virus turning cold tumors hot,